Cancer-Focused Medivir Licenses AMR Centre Promising Superbug Assets

 
• By Sten Stovall
  
Klebsiella
AMRC Will Develop Compounds From Medivir’s Anti-Superbug MBLI Program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business